This study investigates the effects of an investigational medication on people with moderate to severe ulcerative colitis (UC). Ulcerative colitis is a condition that causes inflammation and sores in the lining of the large intestine. The study aims to compare the investigational medication with a placebo, which is an inactive …
This study investigates the rate of relapses in individuals with relapsing forms of multiple sclerosis. Multiple sclerosis (MS) is a condition where the immune system attacks the protective covering of nerves, leading to communication problems between the brain and the rest of the body. The study compares the effects of …
This study investigates the effectiveness and safety of an investigational medication for people with moderate to severe atopic dermatitis (AD). Atopic dermatitis is a skin condition that causes itchy and inflamed skin. The study will compare the investigational medication to a placebo, which is an inactive substance that looks like …
This study investigates the effectiveness of an investigational medication in delaying the progression of disability in individuals with non-relapsing Secondary Progressive Multiple Sclerosis (nrSPMS). nrSPMS is a stage of multiple sclerosis where the disease steadily worsens without relapses. Participants will be randomly assigned to receive either the investigational medication or …
This study investigates the treatment of newly diagnosed moderate or severe chronic graft-versus-host disease (cGVHD). Chronic GVHD is a condition that can occur after a stem cell or bone marrow transplant, where the donor cells attack the recipient's body. The purpose of this study is to evaluate the effectiveness of …
This study investigates the treatment of moderate-to-severe atopic dermatitis (AD) in participants aged 12 years and older. Atopic dermatitis, also known as eczema, is a condition that makes the skin red, inflamed, and itchy. The purpose of this study is to evaluate the effectiveness and safety of an investigational medication …
This study investigates the effectiveness and safety of an investigational medication compared to a placebo in adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). CIDP is a condition where the immune system attacks the nerves, leading to weakness and numbness. The study will focus on participants whose condition has not improved …
This study investigates the effectiveness and safety of an investigational medication compared to intravenous immunoglobulin (IVIg) in adults with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP). CIDP is a neurological disorder that causes progressive weakness and impaired sensory function in the legs and arms. Participants in this study are those who are …
This study investigates the use of an investigational medication in patients who have undergone or will undergo a kidney transplant. The study focuses on a condition called antibody-mediated rejection (AMR), which can occur after a kidney transplant. AMR happens when the body's immune system attacks the new kidney. The study …
This study investigates the effectiveness and safety of an investigational medication for adults with moderate-to-severe rheumatoid arthritis (RA). RA is a condition where the immune system attacks the joints, causing pain and swelling. Participants in this study have RA that is not well-controlled with methotrexate and have not used certain …
